Results 161 to 170 of about 26,826 (219)

Genetic anticipation and cardiac conduction abnormalities in myotonic dystrophy type 1: implications for early stratification from a multicenter registry. [PDF]

Int J Cardiol Heart Vasc
Lorca R, Alen A, Moliner-Abós C, de Frutos F, Báez-Ferrer N, Peña-Peña ML, Villacorta E, Ripoll-Vera T, Zorio E, Martínez-Gimeno A, Bermúdez-Jiménez J, Limeres J, Tiron C, Larrañaga-Moreira JM, Cabrera-Romero E, García-Pavía P, Espinosa MA, Piqueras J, García-Hernández S, Palomino-Doza J, Soriano-Amores M, Moris G, Carrillo-Mora LM, Syris P, Alvarez-Velasco R, Gimeno JR, Muñoz C.   +26 more
europepmc   +1 more source

Differential pathology and susceptibility to MBNL loss across muscles in myotonic dystrophy mouse models. [PDF]

JCI Insight
Davenport ML, Fong A, Montoya-Vazquez G, de Moura MFA, Bubenik JL, Swanson MS.   +5 more
europepmc   +1 more source

Cardiac Involvement in Myotonic Dystrophy Type 1: Mechanisms, Clinical Perspectives, and Emerging Therapeutic Strategies. [PDF]

Int J Mol Sci
Ginjupalli VKM, Reisqs JB, Cupelli M, Chahine M, Boutjdir M.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Myotonic Dystrophy

Continuum, 2022
Myotonic dystrophy type 1 (DM1) and myotonic dystrophy type 2 (DM2) are genetic disorders affecting skeletal and smooth muscle, heart, brain, eyes, and other organs. The multisystem involvement and disease variability of myotonic dystrophy have presented challenges for clinical care and research.
openaire   +2 more sources